Record Quarter for Cantourage Group: EUR 25.6 Million Revenue in Q1

Berlin-based Cantourage Group SE has marked a record-breaking first quarter in 2025, achieving a revenue of EUR 25.6 million. This figure represents a substantial growth compared to EUR 6.1 million in the same period the previous year, prior to the legalization of cannabis. In March alone, Cantourage exceeded its previous monthly record, reaching over EUR 10.7 million in revenue, surpassing the December 2024 figure of EUR 8.5 million.

The company attributes this growth to the increasing demand for its cannabis flowers. In 2024, Cantourage reported revenue of EUR 51.4 million, which is 118% higher than in 2023. Cantourage has expanded its processing capacities in Germany and Portugal and strengthened partnerships, particularly in Canada.

Cantourage continues to lead the European medical cannabis market, with significant demand in Poland and the UK. The firm aims to bolster its market leadership with ongoing global supply chain expansion and a strategic focus on Europe.